{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:13:04Z","timestamp":1788491584944,"version":"build-2803163510"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473058"],"award-info":[{"award-number":["82473058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["821733268"],"award-info":[{"award-number":["821733268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020756","name":"West China School of Stomatology, Sichuan University","doi-asserted-by":"publisher","award":["LCYJ-MS-202308"],"award-info":[{"award-number":["LCYJ-MS-202308"]}],"id":[{"id":"10.13039\/100020756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates formed under chronic inflammatory tumor microenvironments. Clinical cohorts across solid cancers demonstrate that mature TLS with intact germinal centers serve as independent favorable prognostic biomarkers and predict superior responses to immune checkpoint inhibitors. However, the differences in maturity, spatial localization and cellular composition of TLSs result in heterogeneity in their immunostimulation or immunosuppression, thereby exhibiting dual functions of promoting or anti-tumor. Furthermore, there are significant differences in the maturity assessment methods and definitions of TLS, which jointly hinder the clinical evaluation and targeted treatment of TLSs. In this review, we integrate current understanding of TLS development, molecular drivers, and stromal licensing, and dissect the key mechanisms by which TLS contribute to anti-tumor immunity within tumors. We consolidate standardized TLS detection methods encompassing pathology, multi-omics, and radiogenomics, and further explore the translational value of TLS maturation status, germinal center-like responses, and intratumoral versus peritumoral localization in prognosis and immune checkpoint blockade. We systematically elaborate therapeutic strategies for inducing functional TLS, dissect the intrinsic mechanisms by which TLS synergistically boost the efficacy of adoptive cell therapy and tumor vaccines, and outline major bottlenecks hindering clinical translation. Collectively, this work constructs a comprehensive multi-dimensional framework for TLS research and provides actionable insights to develop TLS-targeted immunotherapies for human cancers.<\/jats:p>","DOI":"10.1186\/s43556-026-00562-w","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:23:21Z","timestamp":1788488601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses"],"prefix":"10.1186","volume":"7","author":[{"given":"Zhi-chao","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ling","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"issue":"6","key":"562_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer"},{"issue":"6576","key":"562_CR2","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"T Schumacher","year":"2022","unstructured":"Schumacher T, Thommen D. Tertiary lymphoid structures in cancer. Science (New York, NY). 2022;375(6576):eabf9419. https:\/\/doi.org\/10.1126\/science.abf9419.","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"562_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4049\/jimmunol.2000873","volume":"206","author":"C Gago da Gra\u00e7a","year":"2021","unstructured":"Gago da Gra\u00e7a C, van Baarsen LGM, Mebius RE. Tertiary lymphoid structures: diversity in their development, composition, and role. J Immunol. 2021;206(2):273\u201381. https:\/\/doi.org\/10.4049\/jimmunol.2000873.","journal-title":"J Immunol"},{"issue":"10","key":"562_CR4","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","volume":"56","author":"WH Fridman","year":"2023","unstructured":"Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Saut\u00e8s-Fridman C. Tertiary lymphoid structures and B cells: an intratumoral immunity cycle. Immunity. 2023;56(10):2254\u201369. https:\/\/doi.org\/10.1016\/j.immuni.2023.08.009.","journal-title":"Immunity"},{"issue":"1","key":"562_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao L, Jin S, Wang S, Zhang Z, Wang X, Chen Z, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct Target Ther. 2024;9(1):225. https:\/\/doi.org\/10.1038\/s41392-024-01947-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"562_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","volume":"18","author":"S Deng","year":"2025","unstructured":"Deng S, Chen Y, Song B, Wang H, Huang S, Wu K, et al. Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities. J Hematol Oncol. 2025;18(1):97. https:\/\/doi.org\/10.1186\/s13045-025-01754-7.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"562_CR7","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.medj.2024.10.023","volume":"6","author":"F Peyraud","year":"2025","unstructured":"Peyraud F, Guegan J-P, Vanhersecke L, Brunet M, Teyssonneau D, Palmieri L-J, et al. Tertiary lymphoid structures and cancer immunotherapy: from bench to bedside. Med. 2025;6(1):100546. https:\/\/doi.org\/10.1016\/j.medj.2024.10.023.","journal-title":"Med"},{"issue":"1","key":"562_CR8","doi-asserted-by":"publisher","first-page":"1900508","DOI":"10.1080\/2162402X.2021.1900508","volume":"10","author":"J N","year":"2021","unstructured":"N J, J T, Sl N, Gt B. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies. Oncoimmunology. 2021;10(1):1900508. https:\/\/doi.org\/10.1080\/2162402X.2021.1900508.","journal-title":"Oncoimmunology"},{"issue":"11","key":"562_CR9","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn IP, Magnon G, Gorecki G, Kunning S, Rashid R, Kaiza ME, et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 2024;42(11):1864-81.e5. https:\/\/doi.org\/10.1016\/j.ccell.2024.09.007.","journal-title":"Cancer Cell"},{"issue":"11","key":"562_CR10","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41590-024-01992-w","volume":"25","author":"D Shu","year":"2024","unstructured":"Shu D, Ho W, Kagohara L, Girgis A, Shin S, Danilova L, et al. Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma. Nat Immunol. 2024;25(11):2110\u201323. https:\/\/doi.org\/10.1038\/s41590-024-01992-w.","journal-title":"Nat Immunol"},{"issue":"3","key":"562_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2025.12.011","volume":"44","author":"C Chen","year":"2026","unstructured":"Chen C, An M, Zheng H, Pang M, Li Y, Diao X, et al. B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity. Cancer Cell. 2026;44(3):551-66.e17. https:\/\/doi.org\/10.1016\/j.ccell.2025.12.011.","journal-title":"Cancer Cell"},{"issue":"6","key":"562_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","volume":"43","author":"Z Tang","year":"2025","unstructured":"Tang Z, Bai Y, Fang Q, Yuan Y, Zeng Q, Chen S, et al. Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures. Cancer Cell. 2025;43(6):1025-44.e14. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.011.","journal-title":"Cancer Cell"},{"issue":"1","key":"562_CR13","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41467-025-65421-8","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang G, Zhang X, Liu G, Zhang L, Chen L, et al. Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer. Nat Commun. 2025;16(1):10435. https:\/\/doi.org\/10.1038\/s41467-025-65421-8.","journal-title":"Nat Commun"},{"issue":"8","key":"562_CR14","doi-asserted-by":"publisher","first-page":"e1346","DOI":"10.1002\/ctm2.1346","volume":"13","author":"Q Wang","year":"2023","unstructured":"Wang Q, Sun K, Liu R, Song Y, Lv Y, Bi P, et al. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. Clin Transl Med. 2023;13(8):e1346. https:\/\/doi.org\/10.1002\/ctm2.1346.","journal-title":"Clin Transl Med"},{"key":"562_CR15","doi-asserted-by":"publisher","first-page":"675538","DOI":"10.3389\/fimmu.2021.675538","volume":"12","author":"S Aoyama","year":"2021","unstructured":"Aoyama S, Nakagawa R, Mul\u00e9 JJ, Mailloux AW. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy. Front Immunol. 2021;12:675538. https:\/\/doi.org\/10.3389\/fimmu.2021.675538.","journal-title":"Front Immunol"},{"issue":"1","key":"562_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhang B, Zhang MJ, Li W, Li H, Jiao Y, et al. Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy. Nat Commun. 2025;16(1):44. https:\/\/doi.org\/10.1038\/s41467-024-55430-4.","journal-title":"Nat Commun"},{"issue":"2","key":"562_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","volume":"188","author":"L Onder","year":"2025","unstructured":"Onder L, Papadopoulou C, L\u00fctge A, Cheng H, L\u00fctge M, Perez-Shibayama C, et al. Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. Cell. 2025;188(2):430-46.e20. https:\/\/doi.org\/10.1016\/j.cell.2024.10.042.","journal-title":"Cell"},{"issue":"1","key":"562_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xu M, Ren Y, Ba Y, Liu S, Zuo A, et al. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Mol Cancer. 2024;23(1):75. https:\/\/doi.org\/10.1186\/s12943-024-01980-6.","journal-title":"Mol Cancer"},{"issue":"8","key":"562_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu G, Zeng Q, Wu W, Lei K, Zhang C, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370-85.e9. https:\/\/doi.org\/10.1016\/j.ccell.2024.07.006.","journal-title":"Cancer Cell"},{"issue":"8052","key":"562_CR20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, Zebboudj A, Yano H, Zhang S, Payne G, Chandra A, et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature. 2025;638(8052):1076\u201384. https:\/\/doi.org\/10.1038\/s41586-024-08426-5.","journal-title":"Nature"},{"issue":"12","key":"562_CR21","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s11010-023-04699-y","volume":"478","author":"A Singh","year":"2023","unstructured":"Singh A, Sharma A. Lymphoid tissue inducer cells in cancer: a potential therapeutic target. Mol Cell Biochem. 2023;478(12):2789\u201394. https:\/\/doi.org\/10.1007\/s11010-023-04699-y.","journal-title":"Mol Cell Biochem"},{"key":"562_CR22","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun. 2015;6:8280. https:\/\/doi.org\/10.1038\/ncomms9280.","journal-title":"Nat Commun"},{"key":"562_CR23","doi-asserted-by":"publisher","first-page":"1369626","DOI":"10.3389\/fimmu.2024.1369626","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wu Y, Yan G, Zhang G. Tertiary lymphoid structures in cancer: maturation and induction. Front Immunol. 2024;15:1369626. https:\/\/doi.org\/10.3389\/fimmu.2024.1369626.","journal-title":"Front Immunol"},{"issue":"3","key":"562_CR24","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez AB, Peske JD, Woods AN, Leick KM, Mauldin IS, Meneveau MO, et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 2021;36(3):109422. https:\/\/doi.org\/10.1016\/j.celrep.2021.109422.","journal-title":"Cell Rep"},{"issue":"6","key":"562_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-024-01826-9","volume":"25","author":"X Li","year":"2024","unstructured":"Li X, Mara A, Musial S, Kolling F, Gibbings S, Gerebtsov N, et al. Coordinated chemokine expression defines macrophage subsets across tissues. Nat Immunol. 2024;25(6):1110\u201322. https:\/\/doi.org\/10.1038\/s41590-024-01826-9.","journal-title":"Nat Immunol"},{"key":"562_CR26","doi-asserted-by":"publisher","first-page":"1439413","DOI":"10.3389\/fimmu.2024.1439413","volume":"15","author":"M Reste","year":"2024","unstructured":"Reste M, Ajazi K, Sayi-Yazgan A, Jankovic R, Bufan B, Brandau S, et al. The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases. Front Immunol. 2024;15:1439413. https:\/\/doi.org\/10.3389\/fimmu.2024.1439413.","journal-title":"Front Immunol"},{"key":"562_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-025-00695-8","volume":"14","author":"M Radandish","year":"2025","unstructured":"Radandish M, Mashhadi N, Aghayan AH, Taghizadeh M, Salehianfard S, Yahyazadeh S, et al. In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy. Exp Hematol Oncol. 2025;14:105. https:\/\/doi.org\/10.1186\/s40164-025-00695-8.","journal-title":"Exp Hematol Oncol"},{"issue":"2","key":"562_CR28","doi-asserted-by":"publisher","first-page":"119399","DOI":"10.1016\/j.bbamcr.2022.119399","volume":"1870","author":"L Jin","year":"2023","unstructured":"Jin L, Gao W, Chen P, Zhao W, Zhao Y, Li D, et al. Murine neonatal dermal fibroblast acquires a lymphoid tissue organizer cell-like activity upon synergistic activation of TNF-\u03b1 receptor and LT\u03b2 receptor. Biochim Biophys Acta Mol Cell Res. 2023;1870(2):119399. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119399.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"562_CR29","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/s41467-022-29701-x","volume":"13","author":"S Fleig","year":"2022","unstructured":"Fleig S, Kapanadze T, Bernier-Latmani J, Lill JK, Wyss T, Gamrekelashvili J, et al. Loss of vascular endothelial notch signaling promotes spontaneous formation of tertiary lymphoid structures. Nat Commun. 2022;13:2022. https:\/\/doi.org\/10.1038\/s41467-022-29701-x.","journal-title":"Nat Commun"},{"key":"562_CR30","doi-asserted-by":"publisher","first-page":"736670","DOI":"10.3389\/fimmu.2021.736670","volume":"12","author":"G Vella","year":"2021","unstructured":"Vella G, Guelfi S, Bergers G. High Endothelial Venules: A Vascular Perspective on Tertiary Lymphoid Structures in Cancer. Front Immunol. 2021;12:736670. https:\/\/doi.org\/10.3389\/fimmu.2021.736670.","journal-title":"Front Immunol"},{"issue":"1","key":"562_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41467-024-54686-0","volume":"16","author":"S Nayar","year":"2025","unstructured":"Nayar S, Turner J, Asam S, Fennell E, Pugh M, Colafrancesco S, et al. Molecular and spatial analysis of tertiary lymphoid structures in Sjogren\u2019s syndrome. Nat Commun. 2025;16(1):5. https:\/\/doi.org\/10.1038\/s41467-024-54686-0.","journal-title":"Nat Commun"},{"key":"562_CR32","doi-asserted-by":"publisher","first-page":"102281","DOI":"10.1016\/j.jaut.2019.05.009","volume":"103","author":"K Guedj","year":"2019","unstructured":"Guedj K, Abitbol Y, Cazals-Hatem D, Morvan M, Maggiori L, Panis Y, et al. Adipocytes orchestrate the formation of tertiary lymphoid organs in the creeping fat of Crohn\u2019s disease affected mesentery. J Autoimmun. 2019;103:102281. https:\/\/doi.org\/10.1016\/j.jaut.2019.05.009.","journal-title":"J Autoimmun"},{"issue":"1","key":"562_CR33","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","volume":"15","author":"L Kasikova","year":"2024","unstructured":"Kasikova L, Rakova J, Hensler M, Lanickova T, Tomankova J, Pasulka J, et al. Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer. Nat Commun. 2024;15(1):2528. https:\/\/doi.org\/10.1038\/s41467-024-46873-w.","journal-title":"Nat Commun"},{"issue":"10","key":"562_CR34","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/cmi.2017.13","volume":"14","author":"H Tang","year":"2017","unstructured":"Tang H, Zhu M, Qiao J, Fu Y-X. Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy. Cell Mol Immunol. 2017;14(10):809\u201318. https:\/\/doi.org\/10.1038\/cmi.2017.13.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"562_CR35","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1038\/s41590-025-02259-8","volume":"26","author":"J Sawada","year":"2025","unstructured":"Sawada J, Kikuchi Y, Duah M, Herrera JL, Kanamori F, Csomos K, et al. Simultaneous STING and lymphotoxin-\u03b2 receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity. Nat Immunol. 2025;26(10):1766\u201380. https:\/\/doi.org\/10.1038\/s41590-025-02259-8.","journal-title":"Nat Immunol"},{"issue":"23","key":"562_CR36","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1158\/0008-5472.CAN-23-2716","volume":"84","author":"D An","year":"2024","unstructured":"An D, Chen G, Cheng W-Y, Mohrs K, Adler C, Gupta NT, et al. LT\u03b2R Agonism Promotes Antitumor Immune Responses via Modulation of the Tumor Microenvironment. Cancer Res. 2024;84(23):3984\u20134001. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2716.","journal-title":"Cancer Res"},{"issue":"1","key":"562_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/cmi.2011.48","volume":"9","author":"X Zhang","year":"2012","unstructured":"Zhang X, Lu B. IL-17 initiates tertiary lymphoid organ formation. Cell Mol Immunol. 2012;9(1):9\u201310. https:\/\/doi.org\/10.1038\/cmi.2011.48.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"562_CR38","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1111\/imr.70045","volume":"332","author":"M Zuo","year":"2025","unstructured":"Zuo M, Wang AA, Gommerman JL. Follicle on the Roof: Tertiary Lymphoid Structures in Central Nervous System Autoimmunity. Immunol Rev. 2025;332(1):e70045. https:\/\/doi.org\/10.1111\/imr.70045.","journal-title":"Immunol Rev"},{"key":"562_CR39","doi-asserted-by":"publisher","first-page":"1595070","DOI":"10.3389\/fimmu.2025.1595070","volume":"16","author":"Z Yao","year":"2025","unstructured":"Yao Z, Li G, Pan D, Pei Z, Fang Y, Liu H, et al. Roles and functions of tumor-infiltrating lymphocytes and tertiary lymphoid structures in gastric cancer progression. Front Immunol. 2025;16:1595070. https:\/\/doi.org\/10.3389\/fimmu.2025.1595070.","journal-title":"Front Immunol"},{"issue":"5","key":"562_CR40","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","volume":"12","author":"FR Delvecchio","year":"2021","unstructured":"Delvecchio FR, Fincham REA, Spear S, Clear A, Roy-Luzarraga M, Balkwill FR, et al. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Cell Mol Gastroenterol Hepatol. 2021;12(5):1543\u201365. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.06.023.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"562_CR41","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2353\/ajpath.2007.061275","volume":"171","author":"A Manzo","year":"2007","unstructured":"Manzo A, Bugatti S, Caporali R, Prevo R, Jackson DG, Uguccioni M, et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol. 2007;171(5):1549\u201362. https:\/\/doi.org\/10.2353\/ajpath.2007.061275.","journal-title":"Am J Pathol"},{"issue":"45","key":"562_CR42","doi-asserted-by":"publisher","first-page":"e2409560122","DOI":"10.1073\/pnas.2409560122","volume":"122","author":"R Falahat","year":"2025","unstructured":"Falahat R, Mul\u00e9 JJ. Chemokine\/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity. Proc Natl Acad Sci U S A. 2025;122(45):e2409560122. https:\/\/doi.org\/10.1073\/pnas.2409560122.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"562_CR43","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1111\/cas.70105","volume":"116","author":"M Yoshimitsu","year":"2025","unstructured":"Yoshimitsu M, Nakamura M, Kano S, Magara T, Kato H, Sakai A, et al. CXCL13 and CCL21 induce tertiary lymphoid structures and enhance the efficacy of immunotherapy for melanoma. Cancer Sci. 2025;116(8):2075. https:\/\/doi.org\/10.1111\/cas.70105.","journal-title":"Cancer Sci"},{"key":"562_CR44","doi-asserted-by":"publisher","unstructured":"Kranich J, Krautler NJ. How follicular dendritic cells shape the B-cell antigenome. Front Immunol. 2016;7. https:\/\/doi.org\/10.3389\/fimmu.2016.00225.","DOI":"10.3389\/fimmu.2016.00225"},{"issue":"8076","key":"562_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41586-025-09203-8","volume":"644","author":"Y Dai","year":"2025","unstructured":"Dai Y, Knisely A, Yano M, Dang M, Hinchcliff E, Lee S, et al. PPP2R1A mutations portend improved survival after cancer immunotherapy. Nature. 2025;644(8076):537\u201346. https:\/\/doi.org\/10.1038\/s41586-025-09203-8.","journal-title":"Nature"},{"key":"562_CR46","doi-asserted-by":"publisher","first-page":"113897","DOI":"10.1016\/j.jconrel.2025.113897","volume":"384","author":"C Kuwentrai","year":"2025","unstructured":"Kuwentrai C, Tang W, Lin X, Chi T, Liu D, Song E, et al. Injectable hydrogel-based drug formulation for enhancing tertiary lymphoid structure formation and cancer immunotherapy efficacy. J Control Release. 2025;384:113897. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113897.","journal-title":"J Control Release"},{"issue":"12","key":"562_CR47","doi-asserted-by":"publisher","first-page":"e157215","DOI":"10.1172\/jci.insight.157215","volume":"7","author":"M Ukita","year":"2022","unstructured":"Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, et al. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI insight. 2022;7(12):e157215. https:\/\/doi.org\/10.1172\/jci.insight.157215.","journal-title":"JCI insight"},{"issue":"12","key":"562_CR48","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.ccell.2022.11.002","volume":"40","author":"Y Hua","year":"2022","unstructured":"Hua Y, Vella G, Rambow F, Allen E, Martinez AA, Duhamel M, et al. Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop. Cancer Cell. 2022;40(12):1600-18.e10. https:\/\/doi.org\/10.1016\/j.ccell.2022.11.002.","journal-title":"Cancer Cell"},{"issue":"3","key":"562_CR49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ccell.2023.02.002","volume":"41","author":"G Vella","year":"2023","unstructured":"Vella G, Hua Y, Bergers G. High endothelial venules in cancer: Regulation, function, and therapeutic implication. Cancer Cell. 2023;41(3):527\u201345. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.002.","journal-title":"Cancer Cell"},{"issue":"385","key":"562_CR50","doi-asserted-by":"publisher","first-page":"eaak9679","DOI":"10.1126\/scitranslmed.aak9679","volume":"9","author":"E Allen","year":"2017","unstructured":"Allen E, Jabouille A, Rivera LB, Lodewijckx I, Missiaen R, Steri V, et al. Combined antiangiogenic and anti\u2013PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9(385):eaak9679. https:\/\/doi.org\/10.1126\/scitranslmed.aak9679.","journal-title":"Sci Transl Med"},{"issue":"52","key":"562_CR51","doi-asserted-by":"publisher","first-page":"E5688","DOI":"10.1073\/pnas.1411072112","volume":"111","author":"TD Holmes","year":"2014","unstructured":"Holmes TD, Wilson EB, Black EVI, Benest AV, Vaz C, Tan B, et al. Licensed human natural killer cells aid dendritic cell maturation via TNFSF14\/LIGHT. Proc Natl Acad Sci U S A. 2014;111(52):E5688\u201396. https:\/\/doi.org\/10.1073\/pnas.1411072112.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"562_CR52","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ni.3836","volume":"18","author":"A Johansson-Percival","year":"2017","unstructured":"Johansson-Percival A, He B, Li Z-J, Kjell\u00e9n A, Russell K, Li J, et al. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors. Nat Immunol. 2017;18(11):1207\u201317. https:\/\/doi.org\/10.1038\/ni.3836.","journal-title":"Nat Immunol"},{"key":"562_CR53","doi-asserted-by":"publisher","unstructured":"Ramachandran M, Vaccaro A, van dWT, Georganaki M, Lugano R, Vemuri K et al. Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma. Cancer Cell. 2023;41(6):1134\u201351.e10. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.010.","DOI":"10.1016\/j.ccell.2023.04.010"},{"issue":"1","key":"562_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00262-025-04265-z","volume":"75","author":"S Aoyama","year":"2025","unstructured":"Aoyama S, Noda T, Akita H, Mukai Y, Sasaki K, Hasegawa S, et al. Tumor-associated high endothelial venules are associated with enhanced lymphocyte infiltration and favorable prognosis in resected hepatocellular carcinoma. Cancer immunol. 2025;75(1):20. https:\/\/doi.org\/10.1007\/s00262-025-04265-z.","journal-title":"Cancer immunol"},{"issue":"50","key":"562_CR55","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, Wells RJB, Deonarine A, Chan DS, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110(50):20212\u20137. https:\/\/doi.org\/10.1073\/pnas.1320318110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"562_CR56","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1172\/JCI45817","volume":"122","author":"H Salmon","year":"2012","unstructured":"Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean M-C, Validire P, Trautmann A, et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest. 2012;122(3):899\u2013910. https:\/\/doi.org\/10.1172\/JCI45817.","journal-title":"J Clin Invest"},{"issue":"2","key":"562_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","volume":"24","author":"PDA Vignali","year":"2023","unstructured":"Vignali PDA, DePeaux K, Watson MJ, Ye C, Ford BR, Lontos K, et al. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity. Nat Immunol. 2023;24(2):267\u201379. https:\/\/doi.org\/10.1038\/s41590-022-01379-9.","journal-title":"Nat Immunol"},{"issue":"12","key":"562_CR58","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00109-014-1189-3","volume":"92","author":"SM Hatfield","year":"2014","unstructured":"Hatfield SM, Kjaergaard J, Lukashev D, Belikoff B, Schreiber TH, Sethumadhavan S, et al. Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1\u03b1-dependent and extracellular adenosine-mediated tumor protection. J Mol Med. 2014;92(12):1283\u201392. https:\/\/doi.org\/10.1007\/s00109-014-1189-3.","journal-title":"J Mol Med"},{"issue":"9","key":"562_CR59","doi-asserted-by":"publisher","first-page":"e012613","DOI":"10.1136\/jitc-2025-012613","volume":"13","author":"LA Syding","year":"2025","unstructured":"Syding LA, Pla\u010dkov\u00e1 K, Pavelkov\u00e1 L, Aquino-Perez C, Santegoets SJ, Laco J, et al. High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer. J Immunother Cancer. 2025;13(9):e012613. https:\/\/doi.org\/10.1136\/jitc-2025-012613.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"562_CR60","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41419-025-08376-4","volume":"16","author":"G Petroni","year":"2025","unstructured":"Petroni G, Scolari F, Scoccianti G, Palomba A, Greto D, Romagnoli S, et al. Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma. Cell Death Dis. 2025;16(1):917. https:\/\/doi.org\/10.1038\/s41419-025-08376-4.","journal-title":"Cell Death Dis"},{"issue":"2","key":"562_CR61","doi-asserted-by":"publisher","first-page":"e1378844","DOI":"10.1080\/2162402X.2017.1378844","volume":"7","author":"F Posch","year":"2018","unstructured":"Posch F, Silina K, Leibl S, M\u00fcndlein A, Moch H, Siebenh\u00fcner A, et al. Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer. Oncoimmunology. 2018;7(2):e1378844. https:\/\/doi.org\/10.1080\/2162402X.2017.1378844.","journal-title":"Oncoimmunology"},{"issue":"1","key":"562_CR62","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41467-022-29040-x","volume":"13","author":"N Horeweg","year":"2022","unstructured":"Horeweg N, Workel H, Loiero D, Church D, Vermij L, L\u00e9on-Castillo A, et al. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nat commun. 2022;13(1):1373. https:\/\/doi.org\/10.1038\/s41467-022-29040-x.","journal-title":"Nat commun"},{"issue":"3","key":"562_CR63","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc J, Germain C, Vo-Bourgais TKD, Lupo A, Klein C, Knockaert S, et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res. 2014;74(3):705\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1342.","journal-title":"Cancer Res"},{"key":"562_CR64","doi-asserted-by":"publisher","first-page":"675146","DOI":"10.3389\/fimmu.2021.675146","volume":"12","author":"F Werner","year":"2021","unstructured":"Werner F, Wagner C, Simon M, Glatz K, Mertz KD, L\u00e4ubli H, et al. A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration. Front Immunol. 2021;12:675146. https:\/\/doi.org\/10.3389\/fimmu.2021.675146.","journal-title":"Front Immunol"},{"issue":"19","key":"562_CR65","doi-asserted-by":"publisher","first-page":"e139905","DOI":"10.1172\/JCI139905","volume":"131","author":"G No\u00ebl","year":"2021","unstructured":"No\u00ebl G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG, et al. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J Clin Invest. 2021;131(19):e139905. https:\/\/doi.org\/10.1172\/JCI139905.","journal-title":"J Clin Invest"},{"issue":"1","key":"562_CR66","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang M, Zhang B, Lin W, Li S, Xiong D, et al. Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer. Nat commun. 2025;16(1):4228. https:\/\/doi.org\/10.1038\/s41467-025-59341-w.","journal-title":"Nat commun"},{"key":"562_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-4939-8709-2_5","volume":"1845","author":"K Sili\u0146a","year":"2018","unstructured":"Sili\u0146a K, Burkhardt C, Casanova R, Solterman A, van den Broek M. A Quantitative Pathology Approach to Analyze the Development of Human Cancer-Associated Tertiary Lymphoid Structures. Methods Mol Biol. 2018;1845:71\u201386. https:\/\/doi.org\/10.1007\/978-1-4939-8709-2_5.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"562_CR68","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","volume":"186","author":"J Lin","year":"2023","unstructured":"Lin J, Wang S, Coy S, Chen Y, Yapp C, Tyler M, et al. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer. Cell. 2023;186(2):363-81.e19. https:\/\/doi.org\/10.1016\/j.cell.2022.12.028.","journal-title":"Cell"},{"issue":"6","key":"562_CR69","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00262-022-03310-5","volume":"72","author":"Z Liu","year":"2023","unstructured":"Liu Z, Meng X, Tang X, Zou W, He Y. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma. Cancer immunol. 2023;72(6):1505\u201321. https:\/\/doi.org\/10.1007\/s00262-022-03310-5.","journal-title":"Cancer immunol"},{"key":"562_CR70","doi-asserted-by":"publisher","first-page":"1166497","DOI":"10.3389\/fimmu.2023.1166497","volume":"14","author":"T Shang","year":"2023","unstructured":"Shang T, Jiang T, Lu T, Wang H, Cui X, Pan Y, et al. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma. Front Immunol. 2023;14:1166497. https:\/\/doi.org\/10.3389\/fimmu.2023.1166497.","journal-title":"Front Immunol"},{"issue":"1","key":"562_CR71","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12967-024-05409-y","volume":"22","author":"H Sadeghirad","year":"2024","unstructured":"Sadeghirad H, Monkman J, Tan CW, Liu N, Yunis J, Donovan ML, et al. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response. J Transl Med. 2024;22(1):677. https:\/\/doi.org\/10.1186\/s12967-024-05409-y.","journal-title":"J Transl Med"},{"key":"562_CR72","doi-asserted-by":"publisher","first-page":"648812","DOI":"10.3389\/fimmu.2021.648812","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Liu H, Fu H, Li J, Xu L, Wang G, et al. Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma. Front Immunol. 2021;12:648812. https:\/\/doi.org\/10.3389\/fimmu.2021.648812.","journal-title":"Front Immunol"},{"issue":"7693","key":"562_CR73","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138. https:\/\/doi.org\/10.1038\/nature25501.","journal-title":"Nature"},{"issue":"8","key":"562_CR74","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-23-3325","volume":"84","author":"G Petroni","year":"2024","unstructured":"Petroni G, Pillozzi S, Antonuzzo L. Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. Cancer Res. 2024;84(8):1199\u2013209. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-3325.","journal-title":"Cancer Res"},{"issue":"1","key":"562_CR75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2018.09.003","volume":"70","author":"J Calderaro","year":"2019","unstructured":"Calderaro J, Petitprez F, Becht E, Laurent A, Hirsch TZ, Rousseau B, et al. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma. J Hepatol. 2019;70(1):58\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.003.","journal-title":"J Hepatol"},{"key":"562_CR76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1146\/annurev-immunol-101220-015603","volume":"40","author":"SM Downs-Canner","year":"2022","unstructured":"Downs-Canner SM, Meier J, Vincent BG, Serody JS. B Cell Function in the Tumor Microenvironment. Annu Rev Immunol. 2022;40:169\u201393. https:\/\/doi.org\/10.1146\/annurev-immunol-101220-015603.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"562_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","volume":"15","author":"NS De Silva","year":"2015","unstructured":"De Silva NS, Klein U. Dynamics of B cells in germinal centres. Nat Rev Immunol. 2015;15(3):137\u201348. https:\/\/doi.org\/10.1038\/nri3804.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"562_CR78","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.2425","volume":"17","author":"MA Linterman","year":"2011","unstructured":"Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17(8):975\u201382. https:\/\/doi.org\/10.1038\/nm.2425.","journal-title":"Nat Med"},{"key":"562_CR79","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621\u201363. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101400.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"562_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","volume":"40","author":"N Patil","year":"2022","unstructured":"Patil N, Nabet B, M\u00fcller S, Koeppen H, Zou W, Giltnane J, et al. Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell. 2022;40(3):289-300.e4. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.002.","journal-title":"Cancer Cell"},{"issue":"7791","key":"562_CR81","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577(7791):549\u201355. https:\/\/doi.org\/10.1038\/s41586-019-1922-8.","journal-title":"Nature"},{"issue":"7","key":"562_CR82","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont CM, Banville AC, Gilardi M, Hollern DP, Nelson BH. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev. 2022;22(7):414\u201330. https:\/\/doi.org\/10.1038\/s41568-022-00466-1.","journal-title":"Nat Rev"},{"issue":"2","key":"562_CR83","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7150\/thno.105423","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, Huang Q, Chen X, Zhang B, Liang J, Zhang B. B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Theranostics. 2025;15(2):605\u201331. https:\/\/doi.org\/10.7150\/thno.105423.","journal-title":"Theranostics"},{"issue":"9","key":"562_CR84","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","volume":"28","author":"M Lauss","year":"2022","unstructured":"Lauss M, Donia M, Svane IM, J\u00f6nsson G. B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin Cancer Res. 2022;28(9):1751\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1130.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"562_CR85","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41590-024-01792-2","volume":"25","author":"J Chen","year":"2024","unstructured":"Chen J, Nieman L, Spurrell M, Jorgji V, Elmelech L, Richieri P, et al. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024;25(4):644\u201358. https:\/\/doi.org\/10.1038\/s41590-024-01792-2.","journal-title":"Nat Immunol"},{"issue":"1","key":"562_CR86","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"Y Lu","year":"2022","unstructured":"Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat commun. 2022;13(1):4594. https:\/\/doi.org\/10.1038\/s41467-022-32283-3.","journal-title":"Nat commun"},{"issue":"1","key":"562_CR87","doi-asserted-by":"publisher","first-page":"1900635","DOI":"10.1080\/2162402X.2021.1900635","volume":"10","author":"AJ Gunderson","year":"2021","unstructured":"Gunderson AJ, Rajamanickam V, Bui C, Bernard B, Pucilowska J, Ballesteros-Merino C, et al. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer. Oncoimmunology. 2021;10(1):1900635. https:\/\/doi.org\/10.1080\/2162402X.2021.1900635.","journal-title":"Oncoimmunology"},{"issue":"1","key":"562_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"562_CR89","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.ccell.2025.06.020","volume":"43","author":"M Chen","year":"2025","unstructured":"Chen M, Gao Q, Ning H, Chen K, Gao Y, Yu M, et al. Integrated single-cell and spatial transcriptomics uncover distinct cellular subtypes involved in neural invasion in pancreatic cancer. Cancer Cell. 2025;43(9):1656-76.e10. https:\/\/doi.org\/10.1016\/j.ccell.2025.06.020.","journal-title":"Cancer Cell"},{"issue":"1","key":"562_CR90","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, Wei R, Liu C, Zhao Z, Liu X, Wang Y, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat commun. 2025;16(1):2175. https:\/\/doi.org\/10.1038\/s41467-025-57465-7.","journal-title":"Nat commun"},{"issue":"10","key":"562_CR91","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1084\/jem.20180778","volume":"215","author":"C Fistonich","year":"2018","unstructured":"Fistonich C, Zehentmeier S, Bednarski JJ, Miao R, Schjerven H, Sleckman BP, et al. Cell circuits between B cell progenitors and IL-7+ mesenchymal progenitor cells control B cell development. J Exp Med. 2018;215(10):2586\u201399. https:\/\/doi.org\/10.1084\/jem.20180778.","journal-title":"J Exp Med"},{"key":"562_CR92","doi-asserted-by":"publisher","unstructured":"Fan H, Atiya HI, Wang Y, Pisanic TR, Wang T-H, Shih I-M et al. Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis. Cell Rep. 2020;33(10). https:\/\/doi.org\/10.1016\/j.celrep.2020.108473.","DOI":"10.1016\/j.celrep.2020.108473"},{"issue":"6","key":"562_CR93","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41591-022-01821-3","volume":"28","author":"A Italiano","year":"2022","unstructured":"Italiano A, Bessede A, Pulido M, Bompas E, Piperno-Neumann S, Chevreau C, et al. Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort. Nat Med. 2022;28(6):1199\u2013206. https:\/\/doi.org\/10.1038\/s41591-022-01821-3.","journal-title":"Nat Med"},{"issue":"1","key":"562_CR94","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","volume":"12","author":"AT Ruffin","year":"2021","unstructured":"Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat Commun. 2021;12(1):3349. https:\/\/doi.org\/10.1038\/s41467-021-23355-x.","journal-title":"Nat Commun"},{"issue":"12","key":"562_CR95","doi-asserted-by":"publisher","first-page":"e2306515","DOI":"10.1002\/advs.202306515","volume":"11","author":"Y Zhi","year":"2024","unstructured":"Zhi Y, Wang Q, Zi M, Zhang S, Ge J, Liu K, et al. Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis-Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment. Adv Sci (Weinh). 2024;11(12):e2306515. https:\/\/doi.org\/10.1002\/advs.202306515.","journal-title":"Adv Sci (Weinh)"},{"issue":"7791","key":"562_CR96","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, de Reyni\u00e8s A, Keung EZ, Chen TW, Sun CM, Calderaro J, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577(7791):556\u201360. https:\/\/doi.org\/10.1038\/s41586-019-1906-8.","journal-title":"Nature"},{"issue":"11","key":"562_CR97","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/s41590-024-01990-y","volume":"25","author":"X Liu","year":"2024","unstructured":"Liu X, Duda DG. Involuted TLS as a harbinger of HCC regression. Nat Immunol. 2024;25(11):1986\u20137. https:\/\/doi.org\/10.1038\/s41590-024-01990-y.","journal-title":"Nat Immunol"},{"issue":"12","key":"562_CR98","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1158\/1078-0432.Ccr-15-2762","volume":"22","author":"DR Kroeger","year":"2016","unstructured":"Kroeger DR, Milne K, Nelson BH. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer. Clin Cancer Res. 2016;22(12):3005\u201315. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2762.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"562_CR99","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","volume":"189","author":"C Germain","year":"2014","unstructured":"Germain C, Gnjatic S, Tamzalit F, Knockaert S, Remark R, Goc J, et al. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer. Am J Respir Crit Care Med. 2014;189(7):832\u201344. https:\/\/doi.org\/10.1164\/rccm.201309-1611OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"39","key":"562_CR100","doi-asserted-by":"publisher","first-page":"eadp4942","DOI":"10.1126\/sciadv.adp4942","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Yu B, Ming W, Zhou X, Wang J, Chen D. SpalTopic: a statistical learning framework for exploring tumor spatial architecture from spatially resolved transcriptomic data. Sci Adv. 2024;10(39):eadp4942. https:\/\/doi.org\/10.1126\/sciadv.adp4942.","journal-title":"Sci Adv"},{"issue":"16","key":"562_CR101","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1158\/1078-0432.Ccr-19-2929","volume":"26","author":"M Meylan","year":"2020","unstructured":"Meylan M, Petitprez F, Lacroix L, Di Tommaso L, Roncalli M, Bougo\u00fcin A, et al. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules. Clin Cancer Res. 2020;26(16):4381\u20139. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-2929.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"562_CR102","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","volume":"179","author":"D Coppola","year":"2011","unstructured":"Coppola D, Nebozhyn M, Khalil F, Dai H, Yeatman T, Loboda A, et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am J Pathol. 2011;179(1):37\u201345. https:\/\/doi.org\/10.1016\/j.ajpath.2011.03.007.","journal-title":"Am J Pathol"},{"issue":"7","key":"562_CR103","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1172\/jci67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S, Equeter C, Libin M, de Wind A, et al. CD4\u207a follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873\u201392. https:\/\/doi.org\/10.1172\/jci67428.","journal-title":"J Clin Invest"},{"key":"562_CR104","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","volume":"148","author":"CS Groeneveld","year":"2021","unstructured":"Groeneveld CS, Fontugne J, Cabel L, Bernard-Pierrot I, Radvanyi F, Allory Y, et al. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy. Eur J Cancer. 2021;148:181\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2021.01.036.","journal-title":"Eur J Cancer"},{"issue":"3","key":"562_CR105","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1158\/2326-6066.Cir-24-0299","volume":"13","author":"J Lehmann","year":"2025","unstructured":"Lehmann J, Thelen M, Kreer C, Schran S, Garcia-Marquez MA, Cisic I, et al. Tertiary lymphoid structures in pancreatic cancer are structurally homologous, share gene expression patterns and B-cell clones with secondary lymphoid organs, but show increased T-cell activation. Cancer Immunol Res. 2025;13(3):323\u201336. https:\/\/doi.org\/10.1158\/2326-6066.Cir-24-0299.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"562_CR106","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1097\/js9.0000000000001684","volume":"110","author":"JX Lei","year":"2024","unstructured":"Lei JX, Wang R, Hu C, Lou X, Lv MY, Li C, et al. Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer: a multicenter retrospective cohort study. Int J Surg. 2024;110(9):5627\u201340. https:\/\/doi.org\/10.1097\/js9.0000000000001684.","journal-title":"Int J Surg"},{"key":"562_CR107","doi-asserted-by":"publisher","unstructured":"Long S, Li M, Chen J, Zhong L, Abudulimu A, Zhou L et al. Spatial patterns and MRI-based radiomic prediction of high peritumoral tertiary lymphoid structure density in hepatocellular carcinoma: a multicenter study. J Immunother Cancer. 2024;12(12). https:\/\/doi.org\/10.1136\/jitc-2024-009879.","DOI":"10.1136\/jitc-2024-009879"},{"key":"562_CR108","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.31.630523","author":"L Yoffe","year":"2025","unstructured":"Yoffe L, Bhinder B, Kang SW, Zhang H, Singh A, Ravichandran H, et al. Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer. BioRxiv. 2025. https:\/\/doi.org\/10.1101\/2024.12.31.630523.","journal-title":"BioRxiv"},{"issue":"1","key":"562_CR109","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1002\/mco2.461","volume":"5","author":"W Xu","year":"2020","unstructured":"Xu W, Lu J, Tian X, Ye S, Wei S, Wang J, et al. Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm. 2020;5(1):e461. https:\/\/doi.org\/10.1002\/mco2.461.","journal-title":"MedComm"},{"key":"562_CR110","doi-asserted-by":"publisher","unstructured":"Long S, Li M, Chen J, Zhong L, Dai G, Pan D et al. Transfer learning radiomic model predicts intratumoral tertiary lymphoid structures in hepatocellular carcinoma: a multicenter study. J Immunother Cancer. 2025;13(3). https:\/\/doi.org\/10.1136\/jitc-2024-011126.","DOI":"10.1136\/jitc-2024-011126"},{"issue":"1","key":"562_CR111","doi-asserted-by":"publisher","first-page":"e2252553","DOI":"10.1001\/jamanetworkopen.2022.52553","volume":"6","author":"Z Li","year":"2023","unstructured":"Li Z, Jiang Y, Li B, Han Z, Shen J, Xia Y, et al. Development and Validation of a Machine Learning Model for Detection and Classification of Tertiary Lymphoid Structures in Gastrointestinal Cancers. JAMA Netw Open. 2023;6(1):e2252553. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.52553.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"562_CR112","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s43856-023-00421-7","volume":"4","author":"M van Rijthoven","year":"2024","unstructured":"van Rijthoven M, Obahor S, Pagliarulo F, van den Broek M, Schraml P, Moch H, et al. Multi-resolution deep learning characterizes tertiary lymphoid structures and their prognostic relevance in solid tumors. Commun Med (Lond). 2024;4(1):5. https:\/\/doi.org\/10.1038\/s43856-023-00421-7.","journal-title":"Commun Med (Lond)"},{"key":"562_CR113","doi-asserted-by":"publisher","unstructured":"Wang YQ, Chen WJ, Zhou W, Dong KQ, Zuo L, Xu D et al. Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study. J Immunother Cancer. 2024;12(6). https:\/\/doi.org\/10.1136\/jitc-2023-008613.","DOI":"10.1136\/jitc-2023-008613"},{"issue":"1","key":"562_CR114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13244-025-01906-w","volume":"16","author":"Y Yu","year":"2025","unstructured":"Yu Y, Yang T, Ma P, Zeng Y, Dai Y, Fu Y, et al. Determining the status of tertiary lymphoid structures in invasive pulmonary adenocarcinoma based on chest CT radiomic features. Insights Imaging. 2025;16(1):28. https:\/\/doi.org\/10.1186\/s13244-025-01906-w.","journal-title":"Insights Imaging"},{"key":"562_CR115","doi-asserted-by":"publisher","unstructured":"Xu W, Lu J, Liu WR, Anwaier A, Wu Y, Tian X et al. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma. J Immunother Cancer. 2023;11(12). https:\/\/doi.org\/10.1136\/jitc-2023-006667.","DOI":"10.1136\/jitc-2023-006667"},{"key":"562_CR116","doi-asserted-by":"publisher","unstructured":"Chung SY, Yeh YC, Huang CJ, Chiang NJ, Hsu DS, Chan MH et al. Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma. J Immunother Cancer. 2025;13(1). https:\/\/doi.org\/10.1136\/jitc-2024-010173.","DOI":"10.1136\/jitc-2024-010173"},{"issue":"27","key":"562_CR117","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/jco.2007.15.0284","volume":"26","author":"MC Dieu-Nosjean","year":"2008","unstructured":"Dieu-Nosjean MC, Antoine M, Danel C, Heudes D, Wislez M, Poulot V, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol. 2008;26(27):4410\u20137. https:\/\/doi.org\/10.1200\/jco.2007.15.0284.","journal-title":"J Clin Oncol"},{"issue":"11","key":"562_CR118","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380. https:\/\/doi.org\/10.1038\/s41568-020-0285-7.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"562_CR119","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/0008-5472.Can-17-1987","volume":"78","author":"K Sili\u0146a","year":"2018","unstructured":"Sili\u0146a K, Soltermann A, Attar FM, Casanova R, Uckeley ZM, Thut H, et al. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma. Cancer Res. 2018;78(5):1308\u201320. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-1987.","journal-title":"Cancer Res"},{"issue":"7","key":"562_CR120","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman WH, Meylan M, Petitprez F, Sun CM, Italiano A, Saut\u00e8s-Fridman C. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol. 2022;19(7):441\u201357. https:\/\/doi.org\/10.1038\/s41571-022-00619-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"562_CR121","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/srep00765","volume":"2","author":"JL Messina","year":"2012","unstructured":"Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, et al. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci Rep. 2012;2:765. https:\/\/doi.org\/10.1038\/srep00765.","journal-title":"Sci Rep"},{"issue":"3","key":"562_CR122","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, Petitprez F, Becht E, Bougo\u00fcin A, Pupier G, Calvez A, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55(3):527-41.e5. https:\/\/doi.org\/10.1016\/j.immuni.2022.02.001.","journal-title":"Immunity"},{"issue":"221","key":"562_CR123","doi-asserted-by":"publisher","first-page":"221ra13","DOI":"10.1126\/scitranslmed.3007323","volume":"6","author":"L Maldonado","year":"2014","unstructured":"Maldonado L, Teague JE, Morrow MP, Jotova I, Wu TC, Wang C, et al. Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions. Sci Transl Med. 2014;6(221):221ra13. https:\/\/doi.org\/10.1126\/scitranslmed.3007323.","journal-title":"Sci Transl Med"},{"issue":"12","key":"562_CR124","doi-asserted-by":"publisher","first-page":"e13513","DOI":"10.1111\/cpr.13513","volume":"56","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Gu Q, Zhu L, Zhang S, Wu H, Pu X, et al. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma. Cell Prolif. 2023;56(12):e13513. https:\/\/doi.org\/10.1111\/cpr.13513.","journal-title":"Cell Prolif"},{"key":"562_CR125","doi-asserted-by":"publisher","first-page":"116317","DOI":"10.1016\/j.biopha.2024.116317","volume":"172","author":"B Wang","year":"2024","unstructured":"Wang B, Song B, Li Y, Zhao Q, Tan B. Mapping spatial heterogeneity in gastric cancer microenvironment. Biomed Pharmacother. 2024;172:116317. https:\/\/doi.org\/10.1016\/j.biopha.2024.116317.","journal-title":"Biomed Pharmacother"},{"key":"562_CR126","doi-asserted-by":"publisher","unstructured":"Masuda T, Tanaka N, Takamatsu K, Hakozaki K, Takahashi R, Anno T et al. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer. J Immunother Cancer. 2022;10(3). https:\/\/doi.org\/10.1136\/jitc-2021-003883.","DOI":"10.1136\/jitc-2021-003883"},{"issue":"3","key":"562_CR127","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1002\/cam4.5227","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, Lei X, Jia W, Li J, Nie Y, Mao Z, et al. Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma. Cancer Med. 2023;12(3):3068\u201378. https:\/\/doi.org\/10.1002\/cam4.5227.","journal-title":"Cancer Med"},{"key":"562_CR128","doi-asserted-by":"publisher","unstructured":"Lynch KT, Young SJ, Meneveau MO, Wages NA, Engelhard VH, Slingluff CL, Jr. et al. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. J Immunother Cancer. 2021;9(6). https:\/\/doi.org\/10.1136\/jitc-2020-002273.","DOI":"10.1136\/jitc-2020-002273"},{"issue":"11","key":"562_CR129","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","volume":"68","author":"M Sofopoulos","year":"2019","unstructured":"Sofopoulos M, Fortis SP, Vaxevanis CK, Sotiriadou NN, Arnogiannaki N, Ardavanis A, et al. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer. Cancer Immunol Immunother. 2019;68(11):1733\u201345. https:\/\/doi.org\/10.1007\/s00262-019-02407-8.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"562_CR130","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","volume":"43","author":"NS Joshi","year":"2015","unstructured":"Joshi NS, Akama-Garren EH, Lu Y, Lee DY, Chang GP, Li A, et al. Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses. Immunity. 2015;43(3):579\u201390. https:\/\/doi.org\/10.1016\/j.immuni.2015.08.006.","journal-title":"Immunity"},{"issue":"1","key":"562_CR131","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","volume":"5","author":"P Devi-Marulkar","year":"2022","unstructured":"Devi-Marulkar P, Fastenackels S, Karapentiantz P, Goc J, Germain C, Kaplon H, et al. Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC. Commun Biol. 2022;5(1):1416. https:\/\/doi.org\/10.1038\/s42003-022-04356-y.","journal-title":"Commun Biol"},{"issue":"1","key":"562_CR132","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1038\/s41467-021-26362-0","volume":"12","author":"JW Cho","year":"2021","unstructured":"Cho JW, Park S, Kim G, Han H, Shim HS, Shin S, et al. Dysregulation of T(FH)-B-T(RM) lymphocyte cooperation is associated with unfavorable anti-PD-1 responses in EGFR-mutant lung cancer. Nat Commun. 2021;12(1):6068. https:\/\/doi.org\/10.1038\/s41467-021-26362-0.","journal-title":"Nat Commun"},{"issue":"3","key":"562_CR133","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2024.11.008","volume":"36","author":"TG Chang","year":"2025","unstructured":"Chang TG, Spathis A, Sch\u00e4ffer AA, Gavrielatou N, Kuo F, Jia D, et al. Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer. Ann Oncol. 2025;36(3):309\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2024.11.008.","journal-title":"Ann Oncol"},{"issue":"2","key":"562_CR134","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00262-024-03911-2","volume":"74","author":"S Westbom-Fremer","year":"2025","unstructured":"Westbom-Fremer S, Tran L, Ebbesson A, Martin de la Fuente L, J\u00f6nsson JM, Kannisto P, et al. Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters. Cancer Immunol Immunother. 2025;74(2):56. https:\/\/doi.org\/10.1007\/s00262-024-03911-2.","journal-title":"Cancer Immunol Immunother"},{"issue":"12","key":"562_CR135","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41416-023-02235-9","volume":"128","author":"Y Hayashi","year":"2023","unstructured":"Hayashi Y, Makino T, Sato E, Ohshima K, Nogi Y, Kanemura T, et al. Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors. Br J Cancer. 2023;128(12):2175\u201385. https:\/\/doi.org\/10.1038\/s41416-023-02235-9.","journal-title":"Br J Cancer"},{"key":"562_CR136","doi-asserted-by":"publisher","first-page":"1385802","DOI":"10.3389\/fimmu.2024.1385802","volume":"15","author":"L Li","year":"2024","unstructured":"Li L, Guo Y, Gong B, Wang S, Wang MM, Sun P, et al. Association between tertiary lymphoid structures and clinical outcomes in cancer patients treated with immune checkpoint inhibitors: an updated meta-analysis. Front Immunol. 2024;15:1385802. https:\/\/doi.org\/10.3389\/fimmu.2024.1385802.","journal-title":"Front Immunol"},{"issue":"7791","key":"562_CR137","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577(7791):561\u20135. https:\/\/doi.org\/10.1038\/s41586-019-1914-8.","journal-title":"Nature"},{"issue":"8","key":"562_CR138","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","volume":"2","author":"L Vanhersecke","year":"2021","unstructured":"Vanhersecke L, Brunet M, Gu\u00e9gan JP, Rey C, Bougouin A, Cousin S, et al. Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression. Nat Cancer. 2021;2(8):794\u2013802. https:\/\/doi.org\/10.1038\/s43018-021-00232-6.","journal-title":"Nat Cancer"},{"issue":"10","key":"562_CR139","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.annonc.2022.06.007","volume":"33","author":"M Brunet","year":"2022","unstructured":"Brunet M, Cromb\u00e9 A, Cousin S, Vanhersecke L, Le Loarer F, Bessede A, et al. Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer. Ann Oncol. 2022;33(10):1084\u20135. https:\/\/doi.org\/10.1016\/j.annonc.2022.06.007.","journal-title":"Ann Oncol"},{"key":"562_CR140","doi-asserted-by":"publisher","first-page":"1551259","DOI":"10.3389\/fimmu.2025.1551259","volume":"16","author":"S Xu","year":"2025","unstructured":"Xu S, Li D, Ning T, Lu Y, Sun Y, Bai H, et al. High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer. Front Immunol. 2025;16:1551259. https:\/\/doi.org\/10.3389\/fimmu.2025.1551259.","journal-title":"Front Immunol"},{"issue":"3","key":"562_CR141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41591-022-02189-0","volume":"29","author":"T Cascone","year":"2023","unstructured":"Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, et al. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023;29(3):593\u2013604. https:\/\/doi.org\/10.1038\/s41591-022-02189-0.","journal-title":"Nat Med"},{"issue":"4","key":"562_CR142","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/ni1330","volume":"7","author":"DL Drayton","year":"2006","unstructured":"Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7(4):344\u201353. https:\/\/doi.org\/10.1038\/ni1330.","journal-title":"Nat Immunol"},{"issue":"7","key":"562_CR143","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","volume":"14","author":"BA Heesters","year":"2014","unstructured":"Heesters BA, Myers RC, Carroll MC. Follicular dendritic cells: dynamic antigen libraries. Nat Rev Immunol. 2014;14(7):495\u2013504. https:\/\/doi.org\/10.1038\/nri3689.","journal-title":"Nat Rev Immunol"},{"key":"562_CR144","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2016.00225","volume":"7","author":"J Kranich","year":"2016","unstructured":"Kranich J, Krautler NJ. How follicular dendritic cells shape the B-cell antigenome. Front Immunol. 2016;7:225. https:\/\/doi.org\/10.3389\/fimmu.2016.00225.","journal-title":"Front Immunol"},{"key":"562_CR145","doi-asserted-by":"publisher","unstructured":"No\u00ebl G, Fontsa ML, Garaud S, De Silva P, de Wind A, Van den Eynden GG et al. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity. J Clin Invest. 2021;131(19). https:\/\/doi.org\/10.1172\/jci139905.","DOI":"10.1172\/jci139905"},{"issue":"3","key":"562_CR146","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.immuni.2022.01.018","volume":"55","author":"R Zander","year":"2022","unstructured":"Zander R, Kasmani MY, Chen Y, Topchyan P, Shen J, Zheng S, et al. Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection. Immunity. 2022;55(3):475-93.e5. https:\/\/doi.org\/10.1016\/j.immuni.2022.01.018.","journal-title":"Immunity"},{"issue":"11","key":"562_CR147","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1158\/2326-6066.Cir-20-0432","volume":"8","author":"AB Rodriguez","year":"2020","unstructured":"Rodriguez AB, Engelhard VH. Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy. Cancer Immunol Res. 2020;8(11):1338\u201345. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0432.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"562_CR148","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri1054","volume":"3","author":"RE Mebius","year":"2003","unstructured":"Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol. 2003;3(4):292\u2013303. https:\/\/doi.org\/10.1038\/nri1054.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"562_CR149","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni.2053","volume":"12","author":"J Rangel-Moreno","year":"2011","unstructured":"Rangel-Moreno J, Carragher DM, de la Luz G-H, Hwang JY, Kusser K, Hartson L, et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol. 2011;12(7):639\u201346. https:\/\/doi.org\/10.1038\/ni.2053.","journal-title":"Nat Immunol"},{"issue":"9","key":"562_CR150","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.it.2022.07.002","volume":"43","author":"B Hussain","year":"2022","unstructured":"Hussain B, Kasinath V, Ashton-Rickardt GP, Clancy T, Uchimura K, Tsokos G, et al. High endothelial venules as potential gateways for therapeutics. Trends Immunol. 2022;43(9):728\u201340. https:\/\/doi.org\/10.1016\/j.it.2022.07.002.","journal-title":"Trends Immunol"},{"key":"562_CR151","doi-asserted-by":"publisher","unstructured":"Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A et al. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer. JCI Insight. 2022;7(12). https:\/\/doi.org\/10.1172\/jci.insight.157215.","DOI":"10.1172\/jci.insight.157215"},{"issue":"26","key":"562_CR152","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu G, Tepper A, Falcomat\u00e0 C, Potak HT, Pia L, Amabile A, et al. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 2024;187(26):7492-510.e22. https:\/\/doi.org\/10.1016\/j.cell.2024.10.006.","journal-title":"Cell"},{"issue":"9","key":"562_CR153","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, Houel A, Panouillot M, Riffard C, Dieu-Nosjean MC. Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer. 2024;24(9):629\u201346. https:\/\/doi.org\/10.1038\/s41568-024-00728-0.","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"562_CR154","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1158\/0008-5472.Can-06-0217","volume":"66","author":"M Lukashev","year":"2006","unstructured":"Lukashev M, LePage D, Wilson C, Bailly V, Garber E, Lukashin A, et al. Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res. 2006;66(19):9617\u201324. https:\/\/doi.org\/10.1158\/0008-5472.Can-06-0217.","journal-title":"Cancer Res"},{"key":"562_CR155","doi-asserted-by":"publisher","unstructured":"Schrama D, thor Straten P, Fischer WH, McLellan AD, Br\u00f6cker EB, Reisfeld RA et al. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity. 2001;14(2):111\u201321. https:\/\/doi.org\/10.1016\/s1074-7613(01)00094-2.","DOI":"10.1016\/s1074-7613(01)00094-2"},{"key":"562_CR156","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1038\/ncomms8114","volume":"6","author":"JD Peske","year":"2015","unstructured":"Peske JD, Thompson ED, Gemta L, Baylis RA, Fu YX, Engelhard VH. Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity. Nat Commun. 2015;6:7114. https:\/\/doi.org\/10.1038\/ncomms8114.","journal-title":"Nat Commun"},{"key":"562_CR157","doi-asserted-by":"publisher","unstructured":"Chelvanambi M, Fecek RJ, Taylor JL, Storkus WJ. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. J Immunother Cancer. 2021;9(2). https:\/\/doi.org\/10.1136\/jitc-2020-001906.","DOI":"10.1136\/jitc-2020-001906"},{"key":"562_CR158","doi-asserted-by":"publisher","first-page":"674375","DOI":"10.3389\/fimmu.2021.674375","volume":"12","author":"A Johansson-Percival","year":"2021","unstructured":"Johansson-Percival A, Ganss R. Therapeutic Induction of Tertiary Lymphoid Structures in Cancer Through Stromal Remodeling. Front Immunol. 2021;12:674375. https:\/\/doi.org\/10.3389\/fimmu.2021.674375.","journal-title":"Front Immunol"},{"issue":"5","key":"562_CR159","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2004.09.006","volume":"21","author":"T Cupedo","year":"2004","unstructured":"Cupedo T, Jansen W, Kraal G, Mebius RE. Induction of secondary and tertiary lymphoid structures in the skin. Immunity. 2004;21(5):655\u201367. https:\/\/doi.org\/10.1016\/j.immuni.2004.09.006.","journal-title":"Immunity"},{"issue":"8","key":"562_CR160","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdy218","volume":"29","author":"TR Cottrell","year":"2018","unstructured":"Cottrell TR, Thompson ED, Forde PM, Stein JE, Duffield AS, Anagnostou V, et al. Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC). Ann Oncol. 2018;29(8):1853\u201360. https:\/\/doi.org\/10.1093\/annonc\/mdy218.","journal-title":"Ann Oncol"},{"issue":"5","key":"562_CR161","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","volume":"4","author":"L van Hooren","year":"2023","unstructured":"van Hooren L, Handgraaf SM, Kloosterman DJ, Karimi E, van Mil L, Gassama AA, et al. CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma. Nat Cancer. 2023;4(5):665\u201381. https:\/\/doi.org\/10.1038\/s43018-023-00547-6.","journal-title":"Nat Cancer"},{"key":"562_CR162","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fimmu.2017.00767","volume":"8","author":"G Zhu","year":"2017","unstructured":"Zhu G, Falahat R, Wang K, Mailloux A, Artzi N, Mul\u00e9 JJ. Tumor-Associated Tertiary Lymphoid Structures: Gene-Expression Profiling and Their Bioengineering. Front Immunol. 2017;8:767. https:\/\/doi.org\/10.3389\/fimmu.2017.00767.","journal-title":"Front Immunol"},{"issue":"12","key":"562_CR163","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/nbt1039","volume":"22","author":"S Suematsu","year":"2004","unstructured":"Suematsu S, Watanabe T. Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol. 2004;22(12):1539\u201345. https:\/\/doi.org\/10.1038\/nbt1039.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"562_CR164","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1172\/jci30379","volume":"117","author":"N Okamoto","year":"2007","unstructured":"Okamoto N, Chihara R, Shimizu C, Nishimoto S, Watanabe T. Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest. 2007;117(4):997\u20131007. https:\/\/doi.org\/10.1172\/jci30379.","journal-title":"J Clin Invest"},{"issue":"6","key":"562_CR165","doi-asserted-by":"publisher","first-page":"e1322238","DOI":"10.1080\/2162402x.2017.1322238","volume":"6","author":"AM Weinstein","year":"2017","unstructured":"Weinstein AM, Chen L, Brzana EA, Patil PR, Taylor JL, Fabian KL, et al. Tbet and IL-36\u03b3 cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment. Oncoimmunology. 2017;6(6):e1322238. https:\/\/doi.org\/10.1080\/2162402x.2017.1322238.","journal-title":"Oncoimmunology"},{"key":"562_CR166","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1038\/ncomms8556","volume":"6","author":"SA Bencherif","year":"2015","unstructured":"Bencherif SA, Warren Sands R, Ali OA, Li WA, Lewin SA, Braschler TM, et al. Injectable cryogel-based whole-cell cancer vaccines. Nat Commun. 2015;6:7556. https:\/\/doi.org\/10.1038\/ncomms8556.","journal-title":"Nat Commun"},{"issue":"28","key":"562_CR167","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1016\/j.biomaterials.2009.06.001","volume":"30","author":"A Singh","year":"2009","unstructured":"Singh A, Suri S, Roy K. In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells. Biomaterials. 2009;30(28):5187\u2013200. https:\/\/doi.org\/10.1016\/j.biomaterials.2009.06.001.","journal-title":"Biomaterials"},{"issue":"6","key":"562_CR168","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1172\/jci87624","volume":"127","author":"TT Smith","year":"2017","unstructured":"Smith TT, Moffett HF, Stephan SB, Opel CF, Dumigan AG, Jiang X, et al. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. J Clin Invest. 2017;127(6):2176\u201391. https:\/\/doi.org\/10.1172\/jci87624.","journal-title":"J Clin Invest"},{"key":"562_CR169","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2016.00316","volume":"7","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi Y, Watanabe T. Gel-Trapped Lymphorganogenic Chemokines Trigger Artificial Tertiary Lymphoid Organs and Mount Adaptive Immune Responses In Vivo. Front Immunol. 2016;7:316. https:\/\/doi.org\/10.3389\/fimmu.2016.00316.","journal-title":"Front Immunol"},{"key":"562_CR170","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.biomaterials.2014.10.053","volume":"40","author":"RA Rosalia","year":"2015","unstructured":"Rosalia RA, Cruz LJ, van Duikeren S, Tromp AT, Silva AL, Jiskoot W, et al. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses. Biomaterials. 2015;40:88\u201397. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.10.053.","journal-title":"Biomaterials"},{"issue":"12","key":"562_CR171","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16(12):1235\u201344. https:\/\/doi.org\/10.1038\/ni.3290.","journal-title":"Nat Immunol"},{"key":"562_CR172","doi-asserted-by":"publisher","unstructured":"Mariani E, Lisignoli G, Borz\u00ec RM, Pulsatelli L. Biomaterials: Foreign Bodies or Tuners for the Immune Response? Int J Mol Sci. 2019;20(3). https:\/\/doi.org\/10.3390\/ijms20030636.","DOI":"10.3390\/ijms20030636"},{"key":"562_CR173","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.addr.2017.07.006","volume":"114","author":"L Chung","year":"2017","unstructured":"Chung L, Maestas DR Jr, Housseau F, Elisseeff JH. Key players in the immune response to biomaterial scaffolds for regenerative medicine. Adv Drug Deliv Rev. 2017;114:184\u201392. https:\/\/doi.org\/10.1016\/j.addr.2017.07.006.","journal-title":"Adv Drug Deliv Rev"},{"issue":"18","key":"562_CR174","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1016\/j.biomaterials.2013.02.065","volume":"34","author":"K Garg","year":"2013","unstructured":"Garg K, Pullen NA, Oskeritzian CA, Ryan JJ, Bowlin GL. Macrophage functional polarization (M1\/M2) in response to varying fiber and pore dimensions of electrospun scaffolds. Biomaterials. 2013;34(18):4439\u201351. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.065.","journal-title":"Biomaterials"},{"key":"562_CR175","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/nyas.12403","volume":"1313","author":"S Tinkle","year":"2014","unstructured":"Tinkle S, McNeil SE, M\u00fchlebach S, Bawa R, Borchard G, Barenholz YC, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci. 2014;1313:35\u201356. https:\/\/doi.org\/10.1111\/nyas.12403.","journal-title":"Ann N Y Acad Sci"},{"key":"562_CR176","unstructured":"Definition of primary mode of action of a combination product. Final rule. Fed Regist. 2005;70(164):49848\u201362."},{"issue":"1","key":"562_CR177","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol. 2009;10(1):66\u201374. https:\/\/doi.org\/10.1038\/ni.1668.","journal-title":"Nat Immunol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00562-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00562-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00562-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:23:24Z","timestamp":1788488604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00562-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":177,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00562-w","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This review does not contain data from human patients, human tissues or clinical specimens, so ethics approval and individual participant consent are not required.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"159"}}